Obesity Featured Articles

  1. The Rise — And Stall — Of Retail Pharmacy Clinical Trials 4/23/2026

    As rumors swirl that Walgreens may be reassessing its clinical trials business, this article explores a broader trend: why major retail pharmacy chains like CVS, Walmart, and Kroger have struggled to make the model work at scale.

  2. Justice In Human Participant Research: Reinterpreting Belmont For Contemporary Clinical Trials 4/23/2026

    Experienced IRB professional Stephanie Pyle revisits the Belmont Report to consider what its principle of “justice” means for research studies developed and conducted today. 

  3. Philanthropy Empowers And Accelerates Testing Of Drug Combinations In T1D 4/23/2026

    City of Hope’s Alberto Pugliese, MD, discusses how philanthropic gifts helped launch a landmark multi-center trial to test a combination therapy using repurposed drugs for the treatment of Type 1 Diabetes.

  4. The Patient-Centered Trial Paradigm For Knee Osteoarthritis 4/22/2026

    Although PROs can complicate a trial design, they're essential to reflecting a patient’s true knee OA experience and producing meaningful evidence, explains Katie Mowry, Ph.D., VP of R&D at Organogensis.

  5. Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3) 4/22/2026

    With FDA's Claude-to-Gemini transition underway within Elsa, Kimberly Chew, Esq., and Michael Yang, Esq., offer advice for proactive risk management to safeguard trade secrets and regulatory outcomes in part three of this series on Elsa's AI transition.

  6. How Imaging Workflows Get Derailed: Four Fixes Teams Can Use Now 4/21/2026

    Learn how to prevent data gaps by addressing common imaging challenges through proactive protocol compliance, automated tracking, and streamlined collaboration for better trial outcomes.

  7. How To Improve Patient Engagement In Clinical Trials 4/21/2026

    Stronger patient engagement improves recruitment, retention, and data quality. Reducing burden, improving communication, and meeting real needs can transform trials and keep studies on track.

  8. Where Study Simulation Fits In Clinical Trials 4/21/2026

    Simulation lets teams test assumptions early, showing how design and operations affect timelines, cost, and feasibility — reducing risk and enabling confident, data‑driven decisions.

  9. Caregivers: The Missing Line Item In Trial Budgets 4/21/2026

    More than 60 million Americans are caregivers, holding up a system and clinical research enterprise, yet they are mostly uncompensated for their efforts. That needs to change, says Denise N. Bronner and Marsha Calloway-Campbell.

  10. A New Biomarker Risk Score May Improve Prognosis And Trials In Idiopathic Pulmonary Fibrosis 4/21/2026

    A new biomarker risk score developed by the Pulmonary Fibrosis Foundation's PROLIFIC consortium could serve as the latest prognostic or predictive tool in clinical trials and care. for those diagnosed with idiopathic pulmonary fibrosis (IPF).